Therefore, even though the incidence and risk estimate of ATE in patients with ALK or ROS1 rearrangement in our study were not significantly higher than that in the general lung cancer population, harboring driver genes such as ALK, may increase the risk of ATE generation in a short period after diagnosis with lung cancer. This evidence concerns the gene ROS1 and lung cancer.